TBH this is total bull crap motivated by Medicare cost savings rather than what the evidence base reflects. Painful period of battling this and/or building evidence of efficacy to counter it more strongly down the track (excuse pun).
a 2RT announcement would be great about now, although the one study there isn’t a slam dunk either and needs more research/expenditure.
Could really be a great buying opportunity if the dip is overdone, equally cash burn could become a big concern if revenues stall for a long period.
Ann: Update on Proposed USA Medicare Changes, page-11
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $110.1K | 458.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 432506 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 169560 | 3 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |